OptimizeRx (OPRX) Gains from Investment Securities (2019 - 2020)
OptimizeRx (OPRX) reported Gains from Investment Securities of $110390.0 for Q3 2020, down 60.58% on a YoY basis from $280000.0 in Q4 2019, and up 267.97% sequentially from $30000.0 in Q2 2020.
OptimizeRx (OPRX) Gains from Investment Securities (2019 - 2020) Analysis & Trends
OptimizeRx (OPRX) has 2 years of Gains from Investment Securities data on file, last reported at $110390.0 in Q3 2020.
- For the quarter ending Q3 2020, Gains from Investment Securities fell 60.58% year-over-year to $110390.0; the trailing twelve-month figure through Dec 2020 stood at -$519610.0 (up 18.17% YoY), and the FY2020 full-year result was $140390.0, up 122.11% from the prior year.
- Gains from Investment Securities climbed to $110390.0 in Q3 2020, from $30000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $280000.0 in Q3 2019 to a low of -$660000.0 in Q4 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 31.81 Bn | 24.49 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 14.76 Bn | 13.86 Bn | 482.22 Mn |
| 3 | Healthequity | 8.36 Bn | 8.10 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.91 Bn | 5.60 Bn | 154.23 Mn |
| 5 | 10x Genomics | 5.89 Bn | 5.35 Bn | 106.18 Mn |
| 6 | MiniMed | 4.45 Bn | 4.16 Bn | 480.00 Mn |
| 7 | Waystar Holding | 4.41 Bn | 4.35 Bn | 216.84 Mn |
| 8 | Doximity | 3.93 Bn | 3.18 Bn | 125.97 Mn |
| 9 | Privia Health | 3.10 Bn | 2.68 Bn | - |
| 10 | OptimizeRx | 120.26 Mn | 100.09 Mn | 14.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 110,390.00 |
| Sep 30, 2020 | 110,390.00 |
| Jun 30, 2020 | 30,000.00 |
| Jun 30, 2020 | 30,000.00 |
| Dec 31, 2019 | -660,000.00 |
| Dec 31, 2019 | -660,000.00 |
| Sep 30, 2019 | 280,000.00 |
| Sep 30, 2019 | 280,000.00 |
| Jun 30, 2019 | -107,000.00 |
| Jun 30, 2019 | -107,000.00 |
| Mar 31, 2019 | -148,000.00 |
| Mar 31, 2019 | -148,000.00 |